Boulder, CO, United States of America

Laurent Bellon


Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 239(Granted Patents)


Location History:

  • Boulder, CO (US) (2000 - 2004)
  • Frederick, MD (US) (2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laurent Bellon

Introduction

Laurent Bellon is a prominent inventor based in Boulder, Colorado, known for his significant contributions to the field of molecular biology. With a total of eight patents to his name, Bellon has made remarkable advancements in the modulation of gene expression through novel chemical compositions.

Latest Patents

One of Bellon's latest patents focuses on nucleic acid molecules with novel chemical compositions capable of modulating gene expression. This invention relates to chemically modified nucleic acid molecules that exhibit increased resistance to nucleases and enhanced binding affinity to target nucleic acid molecules. Additionally, it encompasses methods for modulating gene expression using these innovative molecules, along with compositions and cells that incorporate them. Another notable patent involves a method for one-pot deprotection of RNA molecules, showcasing his expertise in RNA technology.

Career Highlights

Throughout his career, Laurent Bellon has worked with several esteemed companies, including Ribozyme Pharmaceuticals, Incorporated and Sirna Therapeutics, Inc. His work in these organizations has contributed to the advancement of therapeutic technologies and the understanding of gene modulation.

Collaborations

Bellon has collaborated with notable professionals in his field, including Christopher T. Workman and Leonid Beigelman. These collaborations have further enriched his research and innovation efforts.

Conclusion

Laurent Bellon's innovative work in the field of molecular biology, particularly in gene expression modulation, has established him as a key figure in the industry. His patents and collaborations reflect his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…